Balancing Cost and Quality in Life Sciences

In pharmaceuticals and biotechnology, cost pressure is a constant reality. Projects need to move quickly, budgets are scrutinised and facilities must respond to changing scientific, regulatory and commercial demands. Yet in Life Sciences, reducing cost can never mean reducing quality. The consequences are too high: rework, compliance risk, operational disruption, higher energy use, and reputational and market loss.

This is where early decision-making matters. The most successful projects are those where quality is designed in from the beginning.

Understanding the real scope early

Cost challenges often arise before design starts. Clients may have a budget, preferred technical route or ambitious objectives. However, these do not always reflect the true requirements of a compliant, safe and future-ready Life Sciences facility. Early engagement helps align scope, operations, compliance needs, growth plans and budget realities, allowing project teams to identify what is essential, what is realistic and what can be phased over time.

4 key questions include:

• What standards must the facility meet now and in future?
• Which areas require GMP, GLP, BSL or cleanroom grade performance?
• Where can flexibility reduce future adaptation costs?
• Which sustainability measures will support long-term operational savings?

This approach helps clients move from cost control as a short-term exercise to cost control as a long-term strategy.

Compliance, safety and long-term value

Pharmaceutical and biotechnology facilities operate under demanding standards. Requirement arounds temperature, humidity, contamination control, process reliability and traceability are becoming more demanding. Clients must navigate European and local regulations, sustainability expectations, stricter quality systems and increasing pressure to operate efficiently. In this environment, cutting corners can create risk rather than saving money.

Deerns helps clients interpret these requirements and translate them into practical design decisions. This is especially important for projects where budgets are fixed. In those cases, the right answer may be a phased approach: delivering what is essential now while creating a clear route for later upgrades.

Modular design as a cost-quality bridge

Laboratory design is one of the clearest examples of how cost and quality can support each other. Modern labs need to be adaptable. Research priorities change, tenants change, technologies change and AI-enabled workflows are beginning to influence how laboratories are planned and used.

Modular design helps clients prepare for that uncertainty. Modularity allows spaces, services and equipment to be adjusted with less disruption and waste.

4 practical benefits:

• Laboratories can adapt to new workflows or tenants.
• Future modifications require less demolition and downtime.
• Smart lab systems can be introduced more easily.
• Facilities retain value because they remain usable for longer.

Multidisciplinary thinking reduces risk

Balancing cost and quality also depends on how a project is organised. Life Sciences facilities involve architecture, MEP engineering, process requirements, contamination control, sustainability, safety, operations and regulatory understanding. If these are handled in isolation, gaps often appear.

A multidisciplinary approach helps avoid costly design gaps by testing decisions from multiple perspectives early, increasing project efficiency. Deerns’ has established a trusted network of specialist suppliers, contractors and laboratory designers, and can help clients select the most suitable partners for project-specific needs rather than simply choosing the cheapest or most familiar option.

Good supplier selection is not simply procurement. It is risk management.

Helping clients make better decisions

Clients do not always approach cost and quality in the same way. A procurement-led discussion may focus on price. A CEO, board member or commercially minded project sponsor may be more open to whole-life value, operational savings and future resilience.

Both perspectives matter. The role of the advisor is to make the trade-offs visible. If a client cannot fund every ambition immediately, the design can still support a structured path forward. If a budget is too low for the required outcome, that must be explained clearly and early. This is where transparent advice creates value.

4 crucial insights for clients:

• what is required for compliance
• what is optional but beneficial
• what can be phased
• what should not be compromised

When this is done well, cost and quality stop being competing forces. They become part of the same decision-making framework.

A stronger future for Life Sciences facilities

Clients need compliant, adaptable and efficient facilities while managing capital responsibly. That balance is not achieved by choosing either cost or quality. It is achieved by making the right decisions early, designing for flexibility and understanding the long-term consequences of every technical choice.

For Deerns, this is where Life Sciences engineering is moving: towards facilities that are not only safe and compliant, but also commercially intelligent, sustainable and future-ready.